Livzon Pharmaceutical details latest A-share repurchase

Livzon Pharmaceutical Group has announced its latest share repurchase activities, with transactions primarily conducted on the Shenzhen Stock Exchange. On September 3, 2025, the company repurchased 71,800 A-shares at prices ranging from RMB 41.38 to RMB 41.99 per share, totaling RMB 2,999,857. These repurchased shares are intended for cancellation.

Prior to this transaction, as of September 2, 2025, the company had 604,293,313 A-shares outstanding. The repurchased amount represents 0.00794% of the existing A-shares before the event. The company's total issued A-shares remained at 604,293,313 as of September 3, 2025, reflecting the status of the repurchased shares as not yet canceled.

This latest repurchase is part of a series of transactions, with the company consistently buying back A-shares throughout late 2024 and 2025. The company confirms that all repurchases comply with relevant listing rules and applicable regulations.